title: Primary mucosa-associated lymphoid tissue lymphoma of the entire esophagus.
authors.affiliation: Institut des Maladies de l'Appareil Digestif, Centre Hospitalier Universitaire de Nantes, Nantes, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Musquer
authors.affiliation: Service d'Anatomo-pathologie, Centre Hospitalier Universitaire d'Angers, Angers, France.
authors.forename: Merzouka
authors.initials: M
authors.lastname: Zidane-Marinnes
authors.affiliation: Service d'Hématologie, Centre Hospitalier Universitaire d'Angers, Angers, France.
authors.forename: Mamoun
authors.initials: M
authors.lastname: Dib
mesh_terms: D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003680:Deglutition Disorders / Q000209:etiology; D004317:Doxorubicin / Q000627:therapeutic use; D004938:Esophageal Neoplasms / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D004945:Esophagoscopy; D005773:Gastroscopy; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone